<DOC>
	<DOCNO>NCT02196636</DOCNO>
	<brief_summary>This two-part study ass safety tolerability single ascend oral dos RO6806127 group healthy male participant investigate effect high fat high caloric food relative bioavailability single oral dose RO6806127 separate group healthy male participant . The relationship drug exposure tolerability explore .</brief_summary>
	<brief_title>A Phase 1 Study RO6806127 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male participant age 18 45 year , inclusive A BMI 18 30 kg/m2 , inclusive Agreement use highly effective contraception Clinically significant abnormality laboratory test result History clinically significant gastrointestinal , renal , hepatic , bronchopulmonary , neurological , psychiatric , cardiovascular , endocrinological , hematological allergic disease , metabolic disorder , cancer cirrhosis Significant disorder central nervous system , include psychiatric disorder , behavioral disturbance , cerebrovascular event , depression , bipolar disorder , migraine , Parkinson , anxiety , personal familial history seizure , epilepsy convulsive condition , previous significant head trauma , factor predispose seizure Use prohibit medication food study start study Dietary restriction would prohibit consumption standardize meal</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>